indazoles has been researched along with Carcinoid Tumor in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chan, JA; Fogelman, DR; Halperin, DM; Hess, KR; Kulke, MH; Malinowski, P; Ng, CS; Phan, AT; Regan, E; Yao, JC | 1 |
| Adhikari, LJ; Ames, MM; Gilbert, JA; Halfdanarson, TR; Lloyd, RV; Muders, MH | 1 |
1 trial(s) available for indazoles and Carcinoid Tumor
| Article | Year |
|---|---|
Pazopanib and depot octreotide in advanced, well-differentiated neuroendocrine tumours: a multicentre, single-group, phase 2 study.
Topics: Aged; Carcinoid Tumor; Cohort Studies; Disease-Free Survival; Female; Humans; Indazoles; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Neuroendocrine Tumors; Pancreatic Neoplasms; Pyrimidines; Receptors, Vascular Endothelial Growth Factor; Sulfonamides; Treatment Outcome | 2015 |
1 other study(ies) available for indazoles and Carcinoid Tumor
| Article | Year |
|---|---|
Molecular markers for novel therapeutic strategies in pancreatic endocrine tumors.
Topics: Axitinib; Benzoquinones; Biomarkers, Tumor; Carcinoid Tumor; Cell Line, Tumor; Cell Survival; Drug Therapy; ErbB Receptors; HSP90 Heat-Shock Proteins; Humans; Imidazoles; Immunohistochemistry; In Situ Hybridization, Fluorescence; Indazoles; Lactams, Macrocyclic; Mutation; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-kit; Proto-Oncogene Proteins p21(ras); Pyrazoles; ras Proteins; Receptor, ErbB-2; Receptor, IGF Type 1; Receptor, Platelet-Derived Growth Factor alpha; Receptor, Transforming Growth Factor-beta Type I; Receptors, Somatostatin; Receptors, Transforming Growth Factor beta; Triazines; Vascular Endothelial Growth Factor Receptor-1 | 2013 |